These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32058031)

  • 21. Diagnostic Role of Blood Tumor Markers in Predicting Hepatocellular Carcinoma in Liver Cirrhosis Patients Undergoing Liver Transplantation.
    Kim Y; Park YH; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Park GC; Lee SG
    Ann Transplant; 2016 Oct; 21():660-667. PubMed ID: 27777395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies.
    Cao LQ; Xie Y; Fleishman JS; Liu X; Chen ZS
    Cancer Lett; 2024 Aug; 597():217061. PubMed ID: 38876384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover.
    Simon J; Ouro A; Ala-Ibanibo L; Presa N; Delgado TC; Martínez-Chantar ML
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron, copper and zinc levels in serum and cirrhotic liver of patients with and without hepatocellular carcinoma.
    Nagasue N; Kolno H; Chang YC; Nakamura T
    Oncology; 1989; 46(5):293-6. PubMed ID: 2550861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Elevated Liver-Type Fatty Acid-Binding Proteins in Liver Diseases.
    Eguchi A; Iwasa M
    Pharm Res; 2021 Jan; 38(1):89-95. PubMed ID: 33534129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation change of alpha-1-acid glycoprotein as a serum biomarker for hepatocellular carcinoma and cirrhosis.
    Zhang D; Huang J; Luo D; Feng X; Liu Y; Liu Y
    Biomark Med; 2017 May; 11(5):423-430. PubMed ID: 28621608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C.
    Nanba S; Ikeda F; Baba N; Takaguchi K; Senoh T; Nagano T; Seki H; Takeuchi Y; Moritou Y; Yasunaka T; Ohnishi H; Miyake Y; Takaki A; Nouso K; Iwasaki Y; Yamamoto K
    J Clin Pathol; 2016 Mar; 69(3):226-33. PubMed ID: 26290259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions.
    Reis H; Bertram S; Pott L; Canbay A; Gallinat A; Baba HA
    Pathol Oncol Res; 2017 Jan; 23(1):33-39. PubMed ID: 27276915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.
    Dhayat SA; Hüsing A; Senninger N; Schmidt HH; Haier J; Wolters H; Kabar I
    PLoS One; 2015; 10(10):e0140066. PubMed ID: 26447841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of liver cancer from blood sera using FTIR microspectroscopy: a preliminary study.
    Thumanu K; Sangrajrang S; Khuhaprema T; Kalalak A; Tanthanuch W; Pongpiachan S; Heraud P
    J Biophotonics; 2014 Apr; 7(3-4):222-31. PubMed ID: 24639420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage.
    Tan J; Song M; Zhou M; Hu Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):17-23. PubMed ID: 28069382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening.
    Simão A; Madaleno J; Silva N; Rodrigues F; Caseiro P; Costa JN; Carvalho A
    BMC Gastroenterol; 2015 Jun; 15():73. PubMed ID: 26122937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis.
    Teng CF; Hsieh WC; Yang CW; Su HM; Tsai TF; Sung WC; Huang W; Su IJ
    Mol Carcinog; 2016 Jan; 55(1):105-14. PubMed ID: 25594851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
    Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
    Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum sphingolipidomic analyses reveal an upregulation of C16-ceramide and sphingosine-1-phosphate in hepatocellular carcinoma.
    Grammatikos G; Schoell N; Ferreirós N; Bon D; Herrmann E; Farnik H; Köberle V; Piiper A; Zeuzem S; Kronenberger B; Waidmann O; Pfeilschifter J
    Oncotarget; 2016 Apr; 7(14):18095-105. PubMed ID: 26933996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH.
    Hwang A; Shi C; Zhu E; Naaz F; Zhou P; Rasheed Z; Liu M; Jung LS; Duan B; Li J; Jiang K; Paka L; Gadhiya SV; Dana D; Ali Q; Yamin MA; Goldberg ID; Narayan P
    PLoS One; 2018; 13(6):e0198937. PubMed ID: 29944670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered lipid profile, oxidative status and hepatitis B virus interactions in human hepatocellular carcinoma.
    Abel S; De Kock M; van Schalkwyk DJ; Swanevelder S; Kew MC; Gelderblom WC
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):391-9. PubMed ID: 19782547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
    Abdel-Hamid NI; El-Azab MF; Moustafa YM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.
    Wang Z; Gou W; Liu M; Sang W; Chu H; Zhang W
    Med Sci Monit; 2015 Oct; 21():3209-15. PubMed ID: 26494212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.